Moreover, as mentioned above, since some studies suggest a correlation between TRPM8′s role in prostate cancer progression and the androgen–dependent state of PCa cells, the efficacy of LNC–WS12s needs to be tested on androgen–dependent PCa cells. Here, TRPM8 is linked to prostate carcinoma.